Publicaciones (177) Publicaciones de JAIME CALVO ALEN

filter_list

2025

  1. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus

  2. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus, Vol. 34, Núm. 6, pp. 571-578

  3. Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort

    Lupus Science and Medicine, Vol. 12, Núm. 2

  4. Doctor-patient communication in Systemic Lupus Erythematosus: Insights from the LupusVoice study

    SSM - Qualitative Research in Health, Vol. 7

  5. Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: Insights from the ARTESER registry

    Rheumatology, Vol. 64, Núm. 9, pp. 4985-4994

  6. Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

    Arthritis Research and Therapy, Vol. 27, Núm. 1

  7. Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data

    Lupus Science and Medicine

  8. Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

    Seminars in Arthritis and Rheumatism, Vol. 74

  9. Systematic literature review of intravenous immunoglobulin use in non-renal and non-hematologic systemic lupus erytehmatosus

    Lupus, Vol. 34, Núm. 3, pp. 261-269

  10. Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients

    Rheumatology, Vol. 64, Núm. 1, pp. 276-282

  11. VEXAS syndrome through a rheumatologist’s lens: insights from a Spanish national cohort

    Rheumatology, Vol. 64, Núm. 6, pp. 3747-3755

2024

  1. Corrigendum to “Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel” [Autoimmunity Reviews, Volume 22, Issue 12, December 2023, 103479] (Autoimmunity Reviews (2023) 22(12), (S1568997223002136), (10.1016/j.autrev.2023.103479))

    Autoimmunity Reviews

  2. Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

    Lupus Science & Medicine, Vol. 11, Núm. 2, pp. e001064

  3. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)

    Rheumatology International, Vol. 44, Núm. 11, pp. 2445-2455

  4. Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study

    Lupus, Vol. 33, Núm. 7, pp. 663-674

  5. Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus

    Reumatologia Clinica, Vol. 20, Núm. 6, pp. 312-319

  6. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

2023

  1. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 58

  2. Coronavirus Disease 2019 in Rheumatic Patientswith Inflammatory Disorders: A Descriptive Study from a High Infection Incidence Region of Northern Spain

    EUROPEAN JOURNAL OF RHEUMATOLOGY, Vol. 10, Núm. 4

  3. Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel

    Autoimmunity Reviews, Vol. 22, Núm. 12